Fresenius Medical Care anticipates significant negative impact on 2021 net income from accelerated COVID-19 related excess mortality of dialysis patients; confirms mid-term targets
k
In with a first position. This will go up again.
E
Goldman Sachs downgraded this stock last week after it fell more than 10% what this means is you should be buying this hand over fist. $52 by end of Q2 !!!!!
E
Pfizer, Moderna and J & J all potentially cause blood clots ...blood clots cause kidney damage.....kidney damage result in Dialysis...buy FMS its the cheapest stock in the Universe ! $80 stock by end of 2022 ! Mortality was released in order to tank these stocks so the big boyz load the boat !!!!!
A
$FMS $FMSPR (Fresenius Medical Care AG & Co) Target Set by Jefferies Sell EUR 60 Target Set by Goldman Sachs Buy EUR 70
S
Can you believe that this was at this price 10 years ago????
M
Would be great if FMS could leverage their tremendous workforce to administer COVID 19 vaccinations.
M
When is Fms going to stop running from the deal they made and Man Up with Akrx?
A
is it time to buy ?
a
Fresenius Medical Care down, because of profit warning due to Covid-19 related issues.
M
Extremely oversold now.
D
buy!!!!!!!! hold!!!!! hold!!!!
A
I’ve been with the company for a couple of years, and just found out it is publicly traded. I could easily assume the returns can’t be good before even checking on it, and I was dead right. I will never be interested in buying this stock
FMS making it's move jump on this train ......heading to $42-$44 in the next 6-8 weeks ! EOY $55 to $60 ! CKD is exploding in this country !
M
FMS should benefit from unfortunate side effect of COVID-19. Kidney damage and medical findings that for some COVID 19 results in sudden onset of insulin dependent diabetes.
J
Why is Abraxane production halted at Melrose Park facility? It contract manufactures to BMS and Beigene. Regulatory issues. Please advise. TomS this is why stock is down.
M
Why isn’t there any action on this board?
B
Not a lot of reason to buy this company other than the dividend.
A
$FMSPR Target Set by JPMorgan Chase Neutral EUR 51.1 Target Set by Deutsche Bank Neutral EUR 65
Target Set by Jefferies Sell EUR 60
Target Set by Goldman Sachs Buy EUR 70
Target Set by JPMorgan Chase Neutral EUR 51.1
Target Set by Deutsche Bank Neutral EUR 65